Tew - PDFSEARCH.IO - Document Search Engine

Tew
Results: 140

#	Item
71	Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV London, United Kingdom, 11 July 2012: Shionogi-ViiV Healthcare LLC today announced that initia Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Organofluorides Medicine Fixed dose combination Bristol-Myers Squibb Cyclopropanes Emtricitabine/tenofovir/efavirenz Antiretroviral drug Abacavir Lamivudine Chemistry Pharmacology Gilead Sciences
72	January 26, 2010 Shionogi & Co., Ltd. A Novel Anti-viral Drug for Influenza, “RAPIACTA 300mg Bag for Intravenous Drip Infusion” and “RAPIACTA 150mg Vial for Intravenous Drip Infusion” Launch Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:22 Pharmacology Carbohydrate chemistry Acetamides Alcohols Guanidines Peramivir Influenza Intravenous therapy Neuraminidase Chemistry Medicine Neuraminidase inhibitors
73	Antitrichomonal Agent, Flagyl® Approval for Additional Indication for Amoebic Dysentery, Giardiasis, Anaerobic Infection and Infectious Enteritis Osaka, Japan, August 10, Shionogi & Co., Ltd. (Head Office: Osaka; Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:25 Infectious diseases Diarrhea Waterborne diseases Giardiasis Shionogi Dysentery Amoebic dysentery Metronidazole Trichomoniasis Medicine Microbiology Health
74	Company Name: Representative: Securities Code: For Inquiries, Contact: Telephone: Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:19 Endocrinology Menopause Menstrual cycle Middle age Shionogi Estrogen Dyspareunia Selective estrogen receptor modulator Vaginal lubrication Anatomy Human reproduction Medicine
75	Shionogi Launches New European Headquarters in London London, 5thJulyJapanese based pharmaceutical company Shionogi & Co., Ltd (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereafter “Shionog Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Pharmaceutical sciences Rosuvastatin Doripenem AstraZeneca Pharmaceutical industry ERT Chemistry Shionogi Organic chemistry
76	Microsoft Word - 20100110KAPVAYCommercialAvailability.docx Add to Reading List Source URL: shionogi616.tew-staging.com Language: English Chemistry Medicine Attention Educational psychology Antihypertensive agents Clonidine Attention deficit hyperactivity disorder Stimulant Attention deficit hyperactivity disorder management Attention-deficit hyperactivity disorder Childhood psychiatric disorders Psychiatry
77	FOR IMMEDIATE RELEASE STUDY DATA SHOW CUVPOSA® REDUCED CHRONIC SEVERE DROOLING IN PATIENTS AGES 3-16 YEARS-OLD WITH NEUROLOGIC CONDITIONS FLORHAM PARK, NJ (January 25, 2012) – Shionogi Inc., the U.S.-based group comp Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:20 Antiemetics Organochlorides Alcohols Janssen Pharmaceutica Piperidines Haloperidol Drooling Aspirin Clinical trial Chemistry Organic chemistry Medicine
78	EMA Accepts MAA Submission of Shionogi’s Ospemifene for the Treatment of VVA London, 27th March 2013 – Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:04 Clinical research Pharmaceutical industry Shionogi European Medicines Agency Clinical trial Risk Food and Drug Administration Pharmaceutical sciences Pharmacology Research
79	Shionogi Launches Carbapenem-Type Antibiotic, “Finibax® 0.5g for Intravenous Drip Infusion” Osaka, Japan, November 29, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi, Ph.D.; hereaft Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:18 Medicine Organic chemistry Doripenem Carbapenem Shionogi Intravenous therapy Ertapenem Antibacterial Carbapenem antibiotics Pyrrolidines Pharmacology
80	Shionogi-ViiV Healthcare Announces Initial Data from Pivotal Phase III Study of Dolutegravir in HIV SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir compared to raltegravir over 48 weeks in treatm Add to Reading List Source URL: shionogi616.tew-staging.com Language: English - Date: 2014-11-03 11:26:24 Health Organic chemistry HIV/AIDS Amides Oxadiazoles Raltegravir Antiretroviral drug ViiV Healthcare GlaxoSmithKline Organofluorides Chemistry Integrase inhibitors

UPDATE